Meetings, Workshops & Trainings
September 25, 2024
Learn More
Meetings, Workshops & Trainings
FDA Safety Communications
FDA Advisory Committee Meetings
Latest Publications & Presentations
Publication
05/06/2026
We describe a ‘plasmode’ simulation-based bias analysis for residual confounding from unmeasured variables by leveraging granular information from a subset of cohort members. We generated 500…
Publication
04/24/2026
An FDA study using Medicare data concluded that among patients aged 65 years or older with nonvalvular atrial fibrillation (NVAF), rivaroxaban had a less favorable benefit-harm profile compared…